Come up with a name for your new list and we'll add to it:
Celladon raised a round of funding on June 24, 2009. Investors include
Qualifying Therapeutic Discovery Project.
Celladon is a biotechnology company developing molecular therapies for the treatment of heart failure. The company's products target the key enzyme deficiency in advanced heart failure, SERCA2a, which…